# Chemicals are booming while everyone stares at AI chaos — long the beaten-down chemical makers

_AI-generated trading idea · BULLISH · DOW, EMN, LYB, XOM_

> Canonical page: https://commonquant.ai/research/for-you/chemicals-are-booming-while-everyone-stares-at-ai-chaos-long--a0996721-bc9b-558f-a6c5-228dbf30f7ec

Dow guiding its largest unit's earnings to nearly double is direct evidence that chemical demand and pricing are inflecting, not just holding. Shell and Exxon putting an $8 billion chemicals unit up for sale shows large owners see the cycle turning well enough to monetize at better prices — asset sales like this often precede sector re-ratings. With jobless claims at levels last seen in the 1960s, the consumer and industrial economy underpinning chemical demand shows no cracks. All this is happening while the market obsesses over AI losses, meaning chemical stocks can catch rotation money at depressed prices.

## Idea

Dow guiding its largest unit's earnings to nearly double is direct evidence that chemical demand and pricing are inflecting, not just holding. Shell and Exxon putting an $8 billion chemicals unit up for sale shows large owners see the cycle turning well enough to monetize at better prices — asset sales like this often precede sector re-ratings. With jobless claims at levels last seen in the 1960s, the consumer and industrial economy underpinning chemical demand shows no cracks. All this is happening while the market obsesses over AI losses, meaning chemical stocks can catch rotation money at depressed prices.

## Advanced Analysis

### Verdict: A credible cycle-turn story, but no entry — wait for the pullback

Over a medium-term horizon, the chemicals-recovery thesis has real support: Eastman's Q2 2026 revenue rose 15.4% to $2.51B with net income up 71% to $183M, LyondellBasell swung to $559M net income with a 12.5-point gross-margin jump, and Dow's losses are shrinking, though Dow still lost $533M in Q1 2026. The strongest point for the trade is that LYB's margin swing is the kind you see when an oversupplied cycle bottoms, and the guidance cited in the Bloomberg piece points the same direction. The strongest point against it is that the anchor ticker is still unprofitable, has cut its dividend roughly in half over two years, and provisional September 30, 2026 filings show Eastman and LYB insiders were net open-market sellers. This is judged on fundamentals alone: the strategy's historical performance was not measured because price bases differed across tickers, and no parameter setup was established. The verdict is wait — not because the thesis is wrong, but because every supplied entry rule is far from triggering while DOW, LYB and XOM all sit with RSI above 70, which is exit territory, not entry territory. A confirmed Dow report showing unit earnings actually doubling, or a price pullback with RSI recovering through 45, would change this assessment.

#### Conviction score breakdown

Composite score computed by the server from the applicable evidence-tier dimensions.

| Measure | Value |
| --- | ---: |
| Thesis support | 65/100 |
| Trade readiness | 15/100 |
| Risk quality | 40/100 |
| Fundamentals trend | 60/100 |
| Score | 45/100 |
| Composite Score | 45/100 |
| Evidence Tier | not\_backtestable |

#### Decision scenarios

Bull, base, and bear cases synthesized from the cited evidence tier. Likelihoods are rounded evidence-weighted judgments, not statistically calibrated forecasts.

| Measure | Value |
| --- | ---: |
| Evidence Tier | not\_backtestable |

### Trade now

\*\*Wait.\*\* The business thesis — chemical demand inflecting, with the idea arguing that Dow's guidance and the Shell/Exxon $8B chemicals sale signal a cycle turn — may or may not be attractive, but today's entry conditions are nowhere near met. The strategy requires price below the 50-day EMA with RSI crossing back above 45 from below. As of the October 24, 2026 observation, DOW closed at $32.61 (above its EMA-50 of $29.80, RSI at 85.4), LYB at $66.45 (EMA-50 of $61.98, RSI at 79.3), and XOM at $179.27 (EMA-50 of $166.13, RSI at 77.7). Every entry rule is marked far from triggering; in fact DOW and LYB already meet one exit condition (RSI above 70), and XOM meets two (RSI above 70 and ADX above 25). Buying here means chasing an overbought move the strategy would be positioned to exit, not enter.

One scope note: historical performance of this rule set was not measured because raw and adjusted price histories for DOW, LYB and XOM use different bases, so no backtested win rate or drawdown figure can be cited to support acting now. Also note EMN was excluded from the quantitative work for insufficient price data, and its latest fundamentals show a $124M free cash flow quarter versus a negative prior quarter — directionally supportive of the thesis but not covered by any live entry rule.

What "wait" means concretely: the pivotal condition is a pullback below the 50-day EMA in at least one of the three names, followed by RSI recovering through 45 while MACD crosses above its signal line. At current prices DOW sits about 9.4% above its EMA-50, LYB about 7.2% above, and XOM about 7.9% above. The downside that matters is that chemical equities can keep running far past overbought readings — the drawdown history of this group (DOW's 59.5% and LYB's 52.2% max drawdown over the 730-day lookback) cuts both ways — so waiting for the defined trigger is not a prediction of a fall, just discipline about entry.

\#\#\# Technical details
Entry rule (per ticker, daily bars): close below the 50-day EMA (a 50-day smoothed average price), the 14-day RSI — a 0–100 momentum gauge — below 45 and crossing back above 45, and the MACD line (12,26,9) crossing above its signal line. Current readings (as of 2026-10-24): DOW $32.61 vs EMA-50 $29.80 (rule distance $2.81), RSI 85.4 vs the 45 threshold; LYB $66.45 vs $61.98 (distance $4.47), RSI 79.3; XOM $179.27 vs $166.13 (distance $13.14), RSI 77.7. MACD-versus-signal rules are marked near on all three, so the RSI and EMA conditions are the binding constraints.

Exit rules: signal exit when 14-day ADX (a trend-strength gauge) exceeds 25, or price falls back below the EMA-50, or RSI exceeds 70, or after 90 bars held. Take profit near the first resistance level or at +4.0% on the position; stop loss at the second support level or −2.0% on the position. Levels: DOW nearest support $32.00, nearest resistance $32.73; LYB support $65.88, resistance $67.00; XOM support $162.74, resistance $180. Because no entry is live, no reward:risk ratio is computed — a concrete calculation will follow once a trigger prints.

#### DOW price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | DOW |
| Timeframe | 1d |

#### LYB price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | LYB |
| Timeframe | 1d |

#### XOM price and trigger map

Uses the idea timeframe and keeps price levels on the price axis.

| Measure | Value |
| --- | ---: |
| Ticker | XOM |
| Timeframe | 1d |

### The Inflection Signal: Chemical Earnings Are Turning Before the Market Notices

Takeaway: the fundamentals in this basket do show a cyclical upturn beginning in the first half of 2026 — most clearly at Eastman and LyondellBasell — and the cited news supports the idea that pricing and demand are inflecting, though Dow's own recovery is earlier-stage and Exxon's chemicals exposure is a partial, not central, beneficiary.

\#\#\# Eastman is the cleanest fundamental confirmation
Eastman's Q2 2026 (period ending June 30) shows the pattern the thesis predicts: revenue up 15.4% quarter over quarter to $2.51B, gross margin up 2.5 points to 22.3%, net income up 71% to $183M, free cash flow positive at $124M after a negative $240M in Q1, and return on equity up to 3.0% from 1.8%. That is a company whose pricing power and volume are improving together — exactly what a demand inflection should look like — and Eastman kept its dividend roughly flat with only a 1.2% annual change, suggesting management believes the recovery is durable rather than a one-quarter bounce.

\#\#\# LyondellBasell's Q2 swing is the strongest magnitude argument
LYB posted the sharpest improvement in the basket: revenue up 27.5% quarter over quarter to $9.18B, gross margin jumping 12.5 points to 22.2%, operating margin moving from 3.3% to 16.8%, net income of $559M versus $125M the prior quarter, and free cash flow swinging from negative $538M to positive $482M. This is not a marginal beat; it is the scale of margin recovery you see when an oversupplied cycle bottoms and spreads widen. If that quarter generalizes across the sector, the market's depressed pricing of these stocks leaves room for re-rating, which is the core of the idea's argument.

\#\#\# Dow's trajectory supports 'inflecting, not recovered' rather than contradicting it
Dow's most recent reported quarter (Q1 2026) still shows a net loss of $533M, but the direction is unambiguously improving: net income improved from a $1.36B loss in Q4 2025, free cash flow swung from negative $284M to positive $621M, operating cash flow quadrupled to $1.12B, and revenue rose 3.5% to $9.79B. Per the Bloomberg piece (October 22, 2026), Dow is guiding its biggest unit's earnings to nearly double this quarter — that guidance is consistent with the Q1 trajectory already visible in the reported numbers. The bull case needs this to continue into Q2 and beyond; one more quarter of improving margins would confirm, and the early evidence supports it.

\#\#\# The asset-sale news and macro backdrop are corroborating, though second-order
Per the FT report via Bloomberg (October 22, 2026), Shell and Exxon put an $8 billion chemicals unit up for sale; the idea reads this as large owners monetizing at better prices ahead of a re-rating, which is a reasonable interpretation — sellers usually act when they expect value to be realized. Exxon itself remains financially strong: Q1 2026 net income of $4.18B and free cash flow of $2.24B, with dividends still growing (4.0% annually, raised to $1.03 per share in August 2026). The CNBC report of jobless claims near 1960s lows supports the demand-side claim that the consumer and industrial economy is not cracking. Interpretation caveat: an asset sale can also mean the seller wants out of a structurally low-return business, so this evidence is supportive but not decisive.

#### DOW Free cash flow

Free cash flow trend from CommonQuant fundamentals/XBRL data; +121.3% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2016-12-31 | $-6446000000 |
| 2017-12-31 | $-7736000000 |
| 2018-03-31 | $-581000000 |
| 2018-06-30 | $1462000000 |
| 2018-09-30 | $154000000 |
| 2018-12-31 | $2163000000 |
| 2018-12-31 | $1084000000 |
| 2019-03-31 | $939000000 |
| 2019-06-30 | $405000000 |
| 2019-09-30 | $1252000000 |
| 2019-12-31 | $3969000000 |
| 2019-12-31 | $1373000000 |
| Latest Value | $1373000000 |
| Change Pct | $121.3000310269935 |
| Ticker | DOW |
| Timeframe | reported periods |

#### LYB Return on equity

Return on equity trend from CommonQuant fundamentals/XBRL data; +106.5% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2012-03-31 | \0.05305039787798408% |
| 2012-06-30 | \0.06700313261399235% |
| 2012-09-30 | \0.06871345029239766% |
| 2012-12-31 | \0.2556782475985277% |
| 2012-12-31 | \0.056737588652482275% |
| 2013-03-31 | \0.07739884889614294% |
| 2013-06-30 | \0.07721077127659574% |
| 2013-09-30 | \0.07183762843186794% |
| 2013-12-31 | \0.30910402308062185% |
| 2013-12-31 | \0.09408559063952555% |
| 2014-03-31 | \0.08014587397167332% |
| 2014-06-30 | \0.10955082302613224% |
| Latest Value | \0.10955082302613224% |
| Change Pct | \106.5033014042593% |
| Ticker | LYB |
| Timeframe | reported periods |

#### DOW sector percentile check

Ranks DOW against 307 companies in its sector using CommonQuant fundamentals.

| Measure | Value |
| --- | ---: |
| Free cash flow | \3.257328990228013th percentile |
| Gross margin | \7.3426573426573425th percentile |
| Revenue growth (YoY) | \16.61341853035144th percentile |
| Ticker | DOW |
| Sector | Materials |
| Peer Count | 307 |

### The Recovery Hasn't Actually Reached Dow's Income Statement Yet

Takeaway: the strongest counter-case is that Dow — the thesis's anchor ticker — is still deeply unprofitable, has cut its dividend nearly in half, and both Eastman and LyondellBasell insiders were net open-market sellers as of the September 2026 filings, which sits awkwardly with the claim that insiders see the cycle turning up. \#\#\# Dow's recovery is a loss-shrinking story, not a profitability story Dow's Q1 2026 net loss of $533M is better than Q4 2025's $1.36B loss, but the company still lost money, and full-year 2025 revenue of $39.97B was down about 9% year over year. Gross margin at 6.5% sits in the bottom 8% of Materials peers, and free cash flow of negative $1.45B for full-year 2025 ranked in the bottom 4% of the peer group. Most telling: Dow cut its dividend from $2.80 per share annually through 2024 to $2.10 in 2025 to $1.05 in 2026 — a 42.9% annual…

#### XOM Debt to equity

Debt to equity trend from CommonQuant fundamentals/XBRL data; +189.8% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2012-12-31 | \0.06724224209136456 ratio |
| 2013-03-31 | \0.0778318692702439 ratio |
| 2013-06-30 | \0.11445423098516726 ratio |
| 2013-09-30 | \0.12350734142810718 ratio |
| 2013-12-31 | \0.12820468612610128 ratio |
| 2014-03-31 | \0.11909998979580266 ratio |
| 2014-06-30 | \0.11810880185476526 ratio |
| 2014-09-30 | \0.11895097653762451 ratio |
| 2014-12-31 | \0.1649550742836828 ratio |
| 2015-03-31 | \0.18940938052993977 ratio |
| 2015-06-30 | \0.19265874394792318 ratio |
| 2015-09-30 | \0.1948360794971972 ratio |
| Latest Value | \0.1948360794971972 ratio |
| Change Pct | \189.75250294668356 ratio |
| Ticker | XOM |
| Timeframe | reported periods |

#### DOW Return on equity

Return on equity trend from CommonQuant fundamentals/XBRL data; -156.5% from first to latest point.

| Measure | Value |
| --- | ---: |
| 2016-12-31 | \0.1661600030784623% |
| 2017-12-31 | \0.014754878629224179% |
| 2017-12-31 | \-0.07872441694431223% |
| 2018-03-31 | \0.05011015272021209% |
| 2018-06-30 | \0.04098889948033579% |
| 2018-09-30 | \0.030908647098309636% |
| 2018-12-31 | \0.1428747344764954% |
| 2018-12-31 | \0.027429732475448693% |
| 2019-03-31 | \0.017019713481082405% |
| 2019-06-30 | \0.004187370889397577% |
| 2019-09-30 | \0.019139030978791886% |
| 2019-12-31 | \-0.093936932279743% |
| Latest Value | \-0.093936932279743% |
| Change Pct | \-156.53402174973786% |
| Ticker | DOW |
| Timeframe | reported periods |

### Scores

- **Conviction score breakdown:** 45
- **Thesis support:** 65
- **Trade readiness:** 15
- **Risk quality:** 40
- **Fundamentals trend:** 60

### Watch items

- **DOW — Close vs 50-day EMA**
- **LYB — Close vs 50-day EMA**
- **XOM — Close vs 50-day EMA**
- **DOW — Weekly jobless claims (demand pillar of thesis)**
- **DOW — Next quarterly report (largest unit earnings guidance)**

## Key details

- Symbols: DOW, EMN, LYB, XOM
- Timeframes: 1d
- Tags: \#canonical-demand, \#cluster-version:1, \#direction:bullish, \#entity-kind:instrument, \#entity:DOW, \#entity:EMN, \#entity:LYB, \#entity:XOM, \#horizon:unspecified, \#intent:research, \#symbol:DOW, \#symbol:EMN, \#symbol:LYB, \#symbol:XOM

## Community

- Upvotes: 0
- Views: 0
- Copies: 0
- Cosigns: 0

## News sources

- [Dow Sees Earnings in Biggest Unit Almost Doubling This Quarter](https://www.bloomberg.com/news/articles/2026-10-22/dow-sees-earnings-in-biggest-unit-almost-doubling-this-quarter) — Bloomberg
- [Shell and Exxon Put $8 Billion Chemical Unit on Block, FT Says](https://www.bloomberg.com/news/articles/2026-10-22/shell-and-exxon-put-8-billion-chemical-unit-on-block-ft-says) — Bloomberg
- [Jobless claims near the lowest since the 1960s as low-fire trend continues](https://www.cnbc.com/2026/10/22/jobless-claims-record-low-weekly.html) — CNBC

## Related

- [DOW trade ideas](https://commonquant.ai/markets/dow)
- [EMN trade ideas](https://commonquant.ai/markets/emn)
- [LYB trade ideas](https://commonquant.ai/markets/lyb)
- [XOM trade ideas](https://commonquant.ai/markets/xom)
- [Latest market news](https://commonquant.ai/news)

## About CommonQuant Research

Ideas and Advanced Analysis are generated with fresh, LLM-selected news headlines and grounded in SEC XBRL fundamentals and peer percentiles. Strategies built from these ideas are automatically backtested (over a timeframe-dependent historical window with walk-forward tuning) and stress-tested before they can go live, then monitored against the news hourly while they run.